FDA warning of opioid interaction with serotonergics

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1595卷 / 1期

关键词：

D O I：

10.1007/s40278-016-16034-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[1] FDA issues safety warning on comfortisivermectin interaction
不详
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2008, 233 (02): : 206 - 206
[2] FDA requires boxed warning for all immediate-release opioid products
Thompson, Cheryl A.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (09) : E114 - E115
[3] FDA VARICELLA WARNING
TINKELMAN, DG
PEDIATRICS, 1992, 90 (03) : 479 - 480
[4] FDA rosiglitazone warning
Kuehn, Bridget M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (24): : 2858 - 2858
[5] FDA Warning for Etravirine
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (11) : 1050 - 1050
[6] FDA Azithromycin Warning
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1413): : 28 - 28
[7] Effect of FDA Warning on Codeine and Alternate Opioid Prescribing After Pediatric Dental Procedures in Ohio
Townsend, Janice A.
Sebastiao, Yuri V.
Cooper, Jennifer N.
PEDIATRIC DENTISTRY, 2019, 41 (06) : 439 - 445
[8] FDA Warning on Dronedarone (Multaq)
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1359): : 17 - 18
[9] FDA issues warning letter
不详
FOOD TECHNOLOGY, 2007, 61 (06) : 12 - 13
[10] The FDA droperidol warning: Is it justified?
Bailey, P
Norton, R
Karan, S
ANESTHESIOLOGY, 2002, 97 (01) : 288 - 289

← 1 2 3 4 5 →